Agios’ Tibsovo gains FDA approval as targeted AML treatment
The US Food and Drug Administration (FDA) has granted approval for Agios Pharmaceuticals' Tibsovo (ivosidenib) tablets to treat adults with…
Agios Pharmaceuticals
The US Food and Drug Administration (FDA) has granted approval for Agios Pharmaceuticals' Tibsovo (ivosidenib) tablets to treat adults with…